Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML
Clinical trial NCT02229266 · TERMINATED
Trial details
- NCT number
- NCT02229266
- Sponsor
- Technische Universität Dresden
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.